{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:21:31Z","timestamp":1778181691693,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastrointestinal stromal tumors (GIST) of the esophagogastric junction might pose a major problem to surgical resection. If locally advanced, extended or multivisceral resection with relevant procedural-specific morbidity and mortality is often necessary.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We report a case of a patient with a locally advanced GIST of the esophagogastric junction who was treated by transhiatal resection of the lower esophagus and gastric cardia with reconstruction by interposition of segment of the jejunum (Merendino procedure). Prior to resection, downsizing of the tumor had successfully been achieved by treatment with imatinib mesylate for six months. Histological proof of GIST by immunohistochemical expression of c-KIT and\/or PDGF alpha Receptor is crucial to allow embarking on this treatment strategy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A multimodal approach for an advanced GIST of the esophagogastric junction with preoperative administration of imatinib mesylate could avoid extended resection. The Merendino procedure might be considered as the reconstruction method of choice after resection of GIST at this location.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-6-37","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T18:13:22Z","timestamp":1207332802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction"],"prefix":"10.1186","volume":"6","author":[{"given":"Wilko I","family":"Staiger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Ronellenfitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Kaehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Ulrich","family":"Schildhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Dimitrakopoulou-Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias HM","family":"Schwarzbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hohenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,4]]},"reference":[{"key":"435_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0242-6498(05)80145-2","volume":"25","author":"JM Coindre","year":"2005","unstructured":"Coindre JM, Emile JF, Monges G, Ranchere-Vince D, Scoazec JY: Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy. Ann Pathol. 2005, 25: 358-385. 10.1016\/S0242-6498(05)80145-2. quiz 357","journal-title":"Ann Pathol"},{"key":"435_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1827.2006.01924.x","volume":"56","author":"S Hirota","year":"2006","unstructured":"Hirota S, Isozaki K: Pathology of gastrointestinal stromal tumors. Pathol Int. 2006, 56: 1-9. 10.1111\/j.1440-1827.2006.02036.x.","journal-title":"Pathol Int"},{"key":"435_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/cncr.20862","volume":"103","author":"B Nilsson","year":"2005","unstructured":"Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG: Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era \u2013 a population-based study in western Sweden. Cancer. 2005, 103: 821-829. 10.1002\/cncr.20862.","journal-title":"Cancer"},{"key":"435_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1572-0241.2005.40709.x","volume":"100","author":"T Tran","year":"2005","unstructured":"Tran T, Davila JA, El-Serag HB: The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005, 100: 162-168. 10.1111\/j.1572-0241.2005.40709.x.","journal-title":"Am J Gastroenterol"},{"key":"435_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-2004-812691","volume":"42","author":"P Reichardt","year":"2004","unstructured":"Reichardt P, Pink D, Mrozek A, Lindner T, Hohenberger P: Gastrointestinal stromal tumors (GIST). Z Gastroenterol. 2004, 42: 327-331. 10.1055\/s-2004-812691.","journal-title":"Z Gastroenterol"},{"key":"435_CR6","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1200\/JCO.2005.05.3439","volume":"24","author":"CP Raut","year":"2006","unstructured":"Raut CP, Posner M, Desai J, Morgan JA, George S, Zahrieh D, Fletcher CD, Demetri GD, Bertagnolli MM: Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol. 2006, 24: 2325-2331. 10.1200\/JCO.2005.05.3439.","journal-title":"J Clin Oncol"},{"key":"435_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jamcollsurg.2006.01.002","volume":"202","author":"EA Perez","year":"2006","unstructured":"Perez EA, Livingstone AS, Franceschi D, Rocha-Lima C, Lee DJ, Hodgson N, Jorda M, Koniaris LG: Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg. 2006, 202: 623-629. 10.1016\/j.jamcollsurg.2006.01.002.","journal-title":"J Am Coll Surg"},{"key":"435_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002, 347: 472-480. 10.1056\/NEJMoa020461.","journal-title":"N Engl J Med"},{"key":"435_CR9","first-page":"3","volume":"54","author":"M Miettinen","year":"2003","unstructured":"Miettinen M, Lasota J: Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003, 54: 3-24.","journal-title":"Pol J Pathol"},{"key":"435_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00000478-199901000-00009","volume":"23","author":"TS Emory","year":"1999","unstructured":"Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol. 1999, 23: 82-87. 10.1097\/00000478-199901000-00009.","journal-title":"Am J Surg Pathol"},{"key":"435_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.athoracsur.2007.05.071","volume":"84","author":"MG Blum","year":"2007","unstructured":"Blum MG, Bilimoria KY, Wayne JD, de Hoyos AL, Talamonti MS, Adley B: Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg. 2007, 84: 1717-1723. 10.1016\/j.athoracsur.2007.05.071.","journal-title":"Ann Thorac Surg"},{"key":"435_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00000478-200002000-00007","volume":"24","author":"M Miettinen","year":"2000","unstructured":"Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J: Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000, 24: 211-222. 10.1097\/00000478-200002000-00007.","journal-title":"Am J Surg Pathol"},{"key":"435_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998, 279: 577-580. 10.1126\/science.279.5350.577.","journal-title":"Science"},{"key":"435_CR14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","volume":"130","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J: Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006, 130: 1466-1478.","journal-title":"Arch Pathol Lab Med"},{"key":"435_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/hupa.2002.123545","volume":"33","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002, 33: 459-465. 10.1053\/hupa.2002.123545.","journal-title":"Hum Pathol"},{"key":"435_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/01.sla.0000219739.11758.27","volume":"243","author":"YW Novitsky","year":"2006","unstructured":"Novitsky YW, Kercher KW, Sing RF, Heniford BT: Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006, 243: 738-745. 10.1097\/01.sla.0000219739.11758.27. discussion 745-7","journal-title":"Ann Surg"},{"key":"435_CR17","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1055\/s-2004-829035","volume":"129","author":"P Hohenberger","year":"2004","unstructured":"Hohenberger P, Reichardt P, Gebauer B, Wardelmann E: Gastrointestinal stromal tumors (GIST) \u2013 current concepts of surgical management. Dtsch Med Wochenschr. 2004, 129: 1817-1820. 10.1055\/s-2004-829035.","journal-title":"Dtsch Med Wochenschr"},{"key":"435_CR18","unstructured":"NCCN guidelines. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/sarcoma.pdf"},{"key":"435_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00104-005-1125-8","volume":"77","author":"P Hohenberger","year":"2006","unstructured":"Hohenberger P, Wardelmann E: Surgical considerations for gastrointestinal stroma tumor. Chirurg. 2006, 77: 33-40. 10.1007\/s00104-005-1125-8.","journal-title":"Chirurg"},{"key":"435_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00104-004-0950-5","volume":"76","author":"I Gockel","year":"2005","unstructured":"Gockel I, Pietzka S, Junginger T: Quality of life after subtotal resection and gastrectomy for gastric cancer. Chirurg. 2005, 76: 250-257. 10.1007\/s00104-004-0950-5.","journal-title":"Chirurg"},{"key":"435_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00000658-195509000-00015","volume":"142","author":"KA Merendino","year":"1955","unstructured":"Merendino KA, Dillard DH: The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg. 1955, 142: 486-506.","journal-title":"Ann Surg"},{"key":"435_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/00000658-200012000-00002","volume":"232","author":"HJ Stein","year":"2000","unstructured":"Stein HJ, Feith M, Mueller J, Werner M, Siewert JR: Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg. 2000, 232: 733-742. 10.1097\/00000658-200012000-00002.","journal-title":"Ann Surg"},{"key":"435_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/jso.20466","volume":"93","author":"P Rutkowski","year":"2006","unstructured":"Rutkowski P, Nowecki Z, Nyckowski P, Dziewirski W, Grzesiakowska U, Nasierowska-Guttmejer A, Krawczyk M, Ruka W: Surgical treatment of patients with initially inoperable and\/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol. 2006, 93: 304-311. 10.1002\/jso.20466.","journal-title":"J Surg Oncol"},{"key":"435_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000, 92: 205-216. 10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst"},{"key":"435_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","volume":"364","author":"J Verweij","year":"2004","unstructured":"Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, Bertulli R, Judson I: Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004, 364: 1127-1134. 10.1016\/S0140-6736(04)17098-0.","journal-title":"Lancet"},{"key":"435_CR26","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1007\/s00330-005-2867-x","volume":"15","author":"C Stroszczynski","year":"2005","unstructured":"Stroszczynski C, Jost D, Reichardt P, Chmelik P, Gaffke G, Kretzschmar A, Schneider U, Felix R, Hohenberger P: Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI. Eur Radiol. 2005, 15: 2448-2456. 10.1007\/s00330-005-2867-x.","journal-title":"Eur Radiol"},{"key":"435_CR27","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2214\/ajr.183.6.01831619","volume":"183","author":"H Choi","year":"2004","unstructured":"Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA: CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol. 2004, 183: 1619-1628.","journal-title":"AJR Am J Roentgenol"},{"key":"435_CR28","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0959-8049(03)00073-X","volume":"39","author":"S Stroobants","year":"2003","unstructured":"Stroobants S, Goeminne J, Seegers M, Dimitrijevic S, Dupont P, Nuyts J, Martens M, van den Borne B, Cole P, Sciot R, Dumez H, Silberman S, Mortelmans L, van Oosterom A: 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer. 2003, 39: 2012-2020. 10.1016\/S0959-8049(03)00073-X.","journal-title":"Eur J Cancer"},{"key":"435_CR29","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","volume":"24","author":"K Ott","year":"2006","unstructured":"Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, Wieder H, Fink U, Schwaiger M, Siewert JR: Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2006, 24: 4692-4698. 10.1200\/JCO.2006.06.7801.","journal-title":"J Clin Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-6-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:00:47Z","timestamp":1630479647000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-6-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-6-37","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,4]]},"assertion":[{"value":"19 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}